Our track record in finding winning penny stocks continues to deliver for our subscribers. In this article, we look at the penny stocks BPSR, CBDD, HMBL, and ILUS to determine whether they are worth your investment.
Volatility when trading penny stocks can be a double-edged sword. However, it highlights one of the significant advantages of trading penny stocks. It is pretty easy for a penny stock to double its price, especially within a short time, but the same cannot be said for large-cap stocks such as Amazon, whose price per share is already huge.
The percentage gain is the crucial point of focus, thus the opportunities in penny stocks. However, investors also need to be careful because prices can also drop drastically.
We constantly remind investors that market opportunities are always there, and it is our goal to find the most promising penny stocks. You can easily make huge profits through penny stocks within a short period.
However, the past few weeks have been quite challenging for OTC investors because many of the most promising OTC stocks peaked in February and have been bearish since then. Fortunately, April brought good tidings as stocks started to rally from around April 21, as we talked about here.
The best bet for investors right now is to identify penny stocks that have not yielded any run. We continuously evaluate hundreds of penny stocks every week and issue alerts on the best ones to our subscribers.
We advise our traders to look for the momentum potential in penny stocks before it happens. Finding momentum before it occurs means securing a good investment position in a stock before a drastic price change occurs.
HMBL is an excellent example of a penny stock that we advised our investors to jump in early while the price was $0.027. You can check out our article on that stock here, as well as ALPP, which we advised traders to get in at $0.075.
Our policy ensures that our subscribers receive priority for the information before it is made available to regular readers. Because of this, we provide an opportunity for our investors to get in early and make significant gains. Many of our subscribers secured their gains, got out at the right time, and could buy back during the dips, thus increasing their profits even more.
The situation this year appears to be vastly different from what we observed last year. NASDAQ penny stocks provided more exposure to profits in the first half of 2020 than the OTC market. We helped our subscribers position themselves well during the year with impressive runs from WKHS, IBIO, INO, NIO, and SRNE. Unfortunately, the momentum was not sustainable due to the pandemic’s impact during summer. We shifted our strategy to OTC penny stocks and tapped into bull runs on stocks like MMEDF, ENZC, and TSNP.
Our attention is currently on cryptos such as Bitcoin and Dogecoin, which are on bullish momentum. EV stocks are not as appealing right now, while SPACs are taking a hit. Penny stock investors are reducing their risk by buying into companies like Alphabet, Wells Fargo, Goldman Sachs, and Amazon, among others.
However, there are still plenty of opportunities for patient investors. Let’s take a look at the following penny stocks.
PENNY STOCKS TO WATCH #1 BPSR
Organicell Regenerative has shown a great performance and is trading well above its 50-Day and 100-Day moving averages of $0.1059 and $0.1467 respectively.
Organicell Regenerative Medicine, Inc. (OTCMKTS: BPSR) is a biopharma that makes regenerative medicine. The company recently announced that its developmental treatment called Zofin™ yielded favorable findings in the first ten people treated with it in India. BPSR entered into a testing and distribution contract with India to develop in February this year. The company also announced that it received the FDA approved its Investigational New Drug (IND) application for Zofin as a therapy for knee osteoarthritis.
The approval will facilitate a placebo-controlled, double-blind phase I/II trial that will seek to establish Zofin’s safety and efficacy profile. BPSR also received the FDA’s approval to commence Zofin’s clinical trial testing in patients suffering from chronic obstructive pulmonary disease (COPD). This is what Dr. Mari Mitrani, Organicell’s Chief Science Officer had to say:
“COPD is a chronic, degenerative, inflammatory lung disease with no current cure. We are excited to initiate this FDA approved clinical trial and to further explore the potential of Zofin in battling this disease.”
Organicell has commenced a randomized, placebo-controlled Phase I/II trial to investigate Zofin as a potential therapy for severe acute respiratory syndrome (SARS) in COVID19 patients.
PENNY STOCKS TO WATCH #2 CBDD
CBD of Denver, Inc. (OTCMKTS: CBDD) has gained momentum over the past six months.
CBD of Denver produces and distributes cannabis and CBD products in Europe, Switzerland, and the U.S. The company’s goal is to continue expanding through equity to secure more assets, especially in Switzerland, as part of its plan to continue generating value for shareholders.
The company managed to maintain its operations despite the impact of the pandemic through its brands BlackPearlCBD and RockFlowr which supported customer reach. CBDD has also maintained a solid customer base thanks to its focus on strong relationships with customers and the delivery of consistently high-quality products.
RockFlowr managed to secure a critical partnership with a U.S-based company that produces and distributes 3,500 lbs of high-quality hemp. The company ordered 400 to 500kg in January this year, and the demand is expected to grow to 1,000kg per week.
CBDD also provides products such as CBD oil which does not have THC. The latter is the active chemical that induces euphoria.
All eyes are now on the Swiss pilot program to permit the temporary production and distribution of marijuana.
“If the pilot program is successful, CBD of Denver, Inc, Rockflowr Exchange, Rockflowr Production and Rockflowr Retail could dramatically benefit by using their expertise in CBD and hemp industry to move into the very lucrative marijuana business,” commented Marcel Gamma, CEO of CBD of Denver. “We look forward to providing additional updates as we execute on this potentially lucrative opportunity.”
PENNY STOCKS TO WATCH #3 HMBL
HUMBL Inc (OTCMKTS: HMBL) hit a high of $7.7 in the month of February, since then it has been hurt by the market maker’s constant naked short selling.
HMBL has built a solid reputation for itself in the digital economy by bringing merchants and consumers together. Its operations are divided into three units, namely HUMBL Financial, HUMBL marketplace, and HUMBL Mobile. They collectively function to deliver digital assets and digital payments to customers across the world.
HUMBL recently made a strategic partnership with Cyberbeat, a Singapore-based financial technology and digital payments platform that operates in the Asia-Pacific region. The partnership will explore expansion and sales in key markets such as Vietnam, India, Nepal, and the Pacific Islands. The extended operations will allow HUMBL to access over 1.5 billion customers.
HUMBL Studios launched a new online shop called HUMBL x SHOP, which will provide merchandise, including collectibles, memorabilia, and apparel. HUMBL announced in mid-April that it rolled out the first version of its new mobile payments platform called HUMBL Pay, which will have features such as tipping, paying, and even rating merchants via contactless transactions. The platform also features ticketing and can connect users to third-party lenders.
Next on the agenda for HUMBL will be the upcoming conference call with CEO Brian Foote and the closing of the Tickeri acquisition. HMBL remains a buy-the-dip opportunity.
PENNY STOCKS TO WATCH #4 ILUS
ILUS gained momentum in the month of January and since then it has gained investor’s attention.
ILUS International Inc (OTCMKTS: ILUS) operates as a holding company that acquires technology companies worldwide. Its latest acquisition is a company known as FB Technologies Global Inc., which makes fire and rescue vehicles, including EV ones. The fire and rescue market has primarily remained underserved; thus, FB Technologies is tapping into the demand, especially now that there is rapid urbanization.
FB Technologies has an MOU with a Dubai and UK-based company called Milanion Group LLC which develops unmanned assets deployed in hostile environments. The MOU will facilitate the development of autonomous Fire & Rescue equipment that target fire and rescue operations, the military, and special operations. The two companies have already been collaborating for the past few months.
ILUS is also launching the ILUS coin, which it hopes will be important and critical for places that traditionally cannot afford to buy critical equipment due to high costs. Coin holders will also receive rewards and facilitate the company’s ability to cater to the high demand. Apart from financial rewards, ILUS coin holders will also get to facilitate the fulfillment of social responsibility. Coin holders will earn rewards after the completion of lease contracts.
The ILUS coin will be rolled out through a brand license financing deal between Toto Capital and ILUS International. According to its whitepaper, coin holders will earn dividends subject to a voting protocol on the coin community. There will be 100 million coins supplied to the market over 24 months. The company expects the coin’s scarcity and desirability to contribute to a higher value in the future.
ILUS has also secured a partnership with a technology agency called Takeleap, which offers virtual reality solutions designed to facilitate a higher level of brand engagement between staff and customers. Takeleap relies on cutting-edge technologies such as virtual reality, augmented reality, artificial intelligence, and machine learning. The partnership aims to commercialize Takeleaf’s products across the world.
The goal will be to tap into the huge growth potential of the virtual reality market valued at $6.1 billion in 2020. Analysts estimate that the market will be worth $20.9 billion by 2025. With a 27.9% CAGR between 2020 and 2025, Takeleap and ILUS see a huge market opportunity which they are currently planning to tap into.
We are constantly reminding our subscribers that the market always provides opportunities, and we are tasked with providing them with information on hot OTC stocks. This allows our subscribers to make huge profits within a short timeframe. If the above four stocks tickled your fancy, then we recommend that you buy the dips. We still recommend swing trades where traders buy dips and sell rips as the best strategy to take advantage of available growth opportunities.
Keep in mind that OTC stocks that are yet to run can potentially provide the most gains. There are hundreds of OTC stocks out there to sift from, but fortunately, our goal is to make it easier for our subscribers by giving them the best alerts. Remember that you can outperform the market indices with just one or two good OTC stocks with healthy returns from a reasonable investment amount.
As always, good luck to all (except the shorts)!
WHEN INSIDER FINANCIAL HAS A STOCK ALERT, IT CAN PAY TO LISTEN. AFTER ALL, OUR FREE NEWSLETTER HAS FOUND MANY TRIPLE-DIGIT WINNERS FOR OUR SUBSCRIBERS. WE SPECIALIZE IN FINDING MOMENTUM BEFORE IT HAPPENS!
Disclosure: We have no position in any of the securities mentioned. We wrote this article ourselves and it expresses our own opinions. We are not receiving compensation for it. We have no business relationship with any company whose stock is mentioned in this article. Insider Financial is not an investment advisor and does not provide investment advice. Always do your own research and make your own investment decisions. This article is not a solicitation or recommendation to buy, sell, or hold securities. This article is meant for informational and educational purposes only and does not provide investment advice.